Gammopathy pp 125-159 | Cite as

The oligoclonal gammopathies

  • János Jákó


In bi- or oligoclonal gammopathies two or more (?) homogeneous populations of monoclonal immunoglobulins can be simultaneously identified in the serum of the patients (39).


Multiple Myeloma Plasma Cell Light Chain Heavy Chain Free Light Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alcalay, M., Reboux, J. F., Vivant, R., Rauvet, J. M., Bontoux, D. Polyarthrite séronégative, vascularité, et double gammapa-thie monoclonale IgA et IgD non myélomateuse. Rev. Rheum. 41, 693. 1974.Google Scholar
  2. 2.
    Arnaud, Ph., Courpron, P., Dechavanne, M., Meunier, P., Vignon, G., Creysell, R. Deux cas de gammapathies biclonales gamma G — lambdagamma A — lambda. Résultats de l’étude métabolique des composants monoclonaux chez l’un des patients. Lyon méd. 236, 129. 1976.Google Scholar
  3. 3.
    Awdeh, Z. L., Williamson, A. R., Askonas, B. A. One cell — one immunoglobulin, origin of limited heterogeneity of myeloma proteins. Biochem.J. 116,241. 1970.PubMedGoogle Scholar
  4. 4.
    Bachman, R. Simultaneous occurence of two immunologically different M components in serum. Acta med. scand. 177, 593. 1965.Google Scholar
  5. 5.
    Ballieux, R. E., Imhof, J. W., Mül, N. A., Zegers, B. J. M. M., Stoop, J. W. Pathology of immunoglobulins. Some aspects of monoclonal gammapathies. Clin.chim. Acta. 22,7. 1968.PubMedGoogle Scholar
  6. 6.
    Basl, E. J. E. G., Slaper-Cortenbach, L. F., Verdonck, L. F., Samson, W., Ballieux, R. E. Transient expression of a second monoclonal component in two forms of biclonal gammopathy. Brit. J. Haematol. 60,91. 1985.Google Scholar
  7. 7.
    Becq-Giraudon, B., Yver, L., Hurez, D., Gombert, L., Alcalay, D. Maladie de Waldenström associée á un syndrome de Sjögren. Double population d’IgM (lambda et kappa). Evolution sous Chlorambucil. Nouv. Presse Méd. 5, 137. 1976.PubMedGoogle Scholar
  8. 8.
    Bihrer, R., Flury, R., Morell, A. Biklonale Paraproteinämie Schweiz, med. Wschr. 104, 39, 1974.Google Scholar
  9. 9.
    Bouvet, J. P., Buffe, D., Oriol, R., Liacopoulos, P. Two myeloma globulins IgG1-kappa and IgG1-lambda from a single patient: II. Their common cellular origin as revealed by immunofluorescence studies. Immunology. 27, 1095. 1974.PubMedGoogle Scholar
  10. 10.
    Bjerrum, O. J., Weeke, B. Two M components (gamma GK and gamma ML) in different cells of same patient. Scand. J. Haemat. 5, 215. 1968.PubMedGoogle Scholar
  11. 11.
    Bouvet, J. P., Feingold, J., Oriol, R., Liacopoulos, P. Statistical study cellular origin of both myeloma globulins. Biomedicine.22,517. 1975.PubMedGoogle Scholar
  12. 12.
    Brenner, S., Milstein, C Origin of antibody variation. Nature. 211,242. 1966.PubMedGoogle Scholar
  13. 13.
    Cebra, J. J., Goldstein, G. Chromatographic purification of tetramethylrhodamine-im-munoglobulin conjugates and their use in cellular localization of rabbit gamma-globulin polypeptide chains. J. Immunol. 95,230. 1965.PubMedGoogle Scholar
  14. 14.
    Chiappino, G., Pernis, B. Demonstration with immunofluorescence of 19S macroglo-bulins and 7S gamma in different cells of human spleen. Path. et. Mocrobiol. 27, 8. 1964.Google Scholar
  15. 15.
    Cooper, M. D., Lawton, A. R., Kincade, P. W. A two stage model for development of antibodyproducing cells. Clin. exp. Immunol. 11,143. 1972.PubMedGoogle Scholar
  16. 16.
    Costea, N., Yakulis, V. J., Libnoch, J. A., Pilz, C. G., Heller, P. Two myeloma globulins (IgG and IgA) in one subject and one cell-line. Amer. J. Med. 42, 630. 1967.PubMedGoogle Scholar
  17. 17.
    Couderc, J., Birrien, J. L., Oriol, R., Bleux, C, Liacopoulos, P. Bispecific cells among IgM and IgG producers during the early phase of primary and secondary responses. Eur. J. Immunol. 5,140. 1975.PubMedGoogle Scholar
  18. 18.
    Creyssel, R., Gibaud, A., Arnaud, Ph., Cordier, J. F. Gammapathies biclonales et oligoclonales. Lyon med. 236,101.1976.Google Scholar
  19. 19.
    Creyssel, R., Brizard, C. P., Gibaud, A., Cordier, J. F., Gibaud, H. Maladie des chaines lourdes gamma d’apparition secondaire au cours de l’évolution d’une macroglobulinémie. Lyon med. 237,101.1977.Google Scholar
  20. 20.
    Curtain, C. C. Immunocytochemical localization of two abnormal serum globulins in one bone-marrow smear. Austr. Ann. Med. 13,136. 1964.Google Scholar
  21. 21.
    Dammacco, F., Trizio, D., Bonomo, L. A case of IgA-kappa myelomatosis with two urinary Bence Jones proteins (BJ-kappa and BJ-lambda) and multiple chromosomal abnormalities. Acta haemat. 41,309. 1969.PubMedGoogle Scholar
  22. 22.
    Davis, M. M., Kim, S. K., Hood, L. Immunoglobulin class switching: developmentally regulated DNA rearrangements during differentiation. Cell. 22,1. 1980.PubMedGoogle Scholar
  23. 23.
    Dittmar, K., Kochwa, S., Zucker-Franklin, D., Wasserman, L.R. Coexistence of polycythaemia vera and biclonal gammo-pathy (gamma GK and gamma AL) with two Bence Jones proteins (BJK and BJL). Blood. 31,81.1968.PubMedGoogle Scholar
  24. 24.
    Dreyerm, W. J., Benett, J. C. The molecular basis of antibody formation: a paradox. Proc. Nat. Acad. Sci. 54, 864. 1965.Google Scholar
  25. 25.
    Engle, R. L., Nachman, R. L. Two Bence Jones proteins of different immunologic types in the same patient with multiple myeloma. Blood. 27, 74.1966.PubMedGoogle Scholar
  26. 26.
    Fahey,J. L. Heterogenety of myeloma proteins. J. Clin. Invest. 42, 111. 1963.PubMedGoogle Scholar
  27. 27.
    Fahey, J. L., Carbone, P. P., Rowe, D. S., Bachmann, R. Plasma cell myeloma with D-myeloma protein (IgD myeloma). Amer. J. Med. 45,373. 1968.PubMedGoogle Scholar
  28. 28.
    Fair, D. S., Krueger, R. G., Gleich, G. J., Kyle, R. A. Studies on IgA and IgG monoclonal proteins derived from a single patient. Evidence of shared individually specific antigenic determinants. J. Immun. 112,201. 1974.PubMedGoogle Scholar
  29. 29.
    Fair, D. S., Krueger, R. G. Analysis of biclonal immunoglobulins and their contributions to understanding the developmental aspects of the antibody response. Contem. Top. mol. Immunol. 7, 51. 1978. 30. Fateh-Moghadam, A., Würz, H., Oeser, R. M., Knedel, M. Doppelparaproteinämie. Dtsch. med. Wschr. 36,1965.1968.Google Scholar
  30. 30.
    Fateh-Moghadam, A., Würz, H., Oeser, R. M., Knedel, M. Doppelparaproteinämie. Dtsch. med. Wschr. 36,1965.1968.Google Scholar
  31. 31.
    Fateh-Moghadam, A., Beil, E., Borchers, H., Asamer, M., Raab, Ch. Plasmozytom, Makroglobulinämie Waldenström und Morbus Paget bei einem Patienten mit IgA-kappa + IgM-kappa Doppelparaproteinämie und Bence Jones Protein (Typ kappa). Blut. 21,146.1970.PubMedGoogle Scholar
  32. 32.
    Fine, J. M., Zakin, M. M., Faure, A., Ropertz, G., Rivat, C.,Rivat,L.,Boffa, G. A. Étude immunochemique de 5 cas dysglobulinémies „biclona-les”. Rev. Franc. de Transfusion. 11,223.1968. 33. Finegold, L, Fahey, J. L., Dutcher,T. F. Immunofluorescent studies of immunoglobulins in human lymphoid cells in continuous culture. J. Immunol. 101,366.1968.Google Scholar
  33. 33.
    Finegold, L, Fahey, J. L., Dutcher,T. F. Immunofluorescent studies of immunoglobulins in human lymphoid cells in continuous culture. J. Immunol. 101,366.1968.PubMedGoogle Scholar
  34. 34.
    Fu, S. M., Winchester, R. J., Feizi, T., Walzer, P. D., Kunkel, H. G. Occurence of surface IgM IgD and free light chains of human lymphocytes. J. exp. Med. 139,451.1974. 35. Fudenberg,H.H.,Wang,A.C,Ping,J.R.L.,Levin,A.S. Studies of an unusual gammapathy: implications with regard to genetic control of normal immunoglobulin synthesis. Amer. N. Y. Acad. Sci. 190, 501. 1971. 36. Gaily, J. A., Edelman, G. M. The genetic control of immunoglobulin synthesis. Ann. Rev. Genet. 6,1. 1972.PubMedGoogle Scholar
  35. 35.
    Fudenberg,H.H.,Wang,A.C,Ping,J.R.L.,Levin,A.S. Studies of an unusual gammapathy: implications with regard to genetic control of normal immunoglobulin synthesis. Amer. N. Y. Acad. Sci. 190, 501. 1971. 36. Gaily, J. A., Edelman, G. M. The genetic control of immunoglobulin synthesis. Ann. Rev. Genet. 6,1. 1972.Google Scholar
  36. 36.
    Gaily, J. A., Edelman, G. M. The genetic control of immunoglobulin synthesis. Ann. Rev. Genet. 6,1. 1972.Google Scholar
  37. 37.
    Gearhart, P. J., Sigal, N. H., Klinman, N. R. Production of antibodies of identical idiotype but diverse immunoglobulin classes by cells derived from a single stimulated B cell. Proc. nat. Acad. Sci. 72,1707.1975.PubMedGoogle Scholar
  38. 38.
    Gearhart, P. J., Hurwitz, J. L., Cebra, J. J. Successive switching of antibody isotypes expressed within the lines of a B-cell clone. Proc. nat. Acad. Sci. 77,5424.1980.PubMedGoogle Scholar
  39. 39.
    Harboe, M., Hannestad, K., Sletten, K. Oligoclonal macroglobulinaemia. Scand. J. Immun. 1,13. 1972.Google Scholar
  40. 40.
    Hijmans, W., Schuit, H. R. E., Klein, R. An immunfluorescence procedure for the detection of intracellular immunoglobulins. Clin. exp. Immunol. 4,457. 1969.PubMedGoogle Scholar
  41. 41.
    Hijmans, W., Schuit, H. R. E., Hulsing-Hesselink, E. An immunfluorescence study an intracellular immunoglobulins. Ann. N. Y. Acad. Sci. 177, 290. 1971.PubMedGoogle Scholar
  42. 42.
    Hijmans, W., Schuit, H. R. E. Immunfluorescence studies an immunoglobulins in the lymphoid cells of human peripherial blood Clin. exp. Immunol. 11, 483. 1972.PubMedGoogle Scholar
  43. 43.
    Hijmans, W. Waldenström’s disease with an IgA paraprotein. Acta med. scand. 198,519. 1975.PubMedGoogle Scholar
  44. 44.
    Hopper, J. E. Immunofluorescent evidence for a common clonal origin of IgM-lambda and IgG-kappa paraproteins. Clin. Res. 21,557.1973.Google Scholar
  45. 45.
    Hopper, J. E. Comparative studies on monotypic IgM-lambda and IgG-kappa from an individual patient. Evidence for shared VH idiotypic determinants. J. Immun. 115,1101. 1975.PubMedGoogle Scholar
  46. 46.
    Hopper, J. E., Cera, L. The structure of human immunoglobulins. Ann. Clin. Lab. Sci. 8,201.1978.PubMedGoogle Scholar
  47. 47.
    Imhof, J. W., Ballieux, R. E., Mul, N. A. J., Poen, H. Monoclonal and diclonal gammopathies. Acta med. scand. 179, (suppl. 445.) 102. 1966.Google Scholar
  48. 48.
    Isobe, T., Osserman, E. F. Plasma-cell dyscrasia associated with the production of incomplete deleted IgG-lambda molecules, gamma heavy-chains and free lambda-chains containing carbohydrates, description of the first case. Blood. 43,505.1974.PubMedGoogle Scholar
  49. 49.
    István, L., Hindy, I., Eckhardt, S. Adatok a plasmocytoma klinikumához, kezeléséhez és gondozásához Orv. Hetil. 117,11. 1976.PubMedGoogle Scholar
  50. 50.
    Jákó, J. Fehérjeanyagcsere-vizsgálatok májbetegségekben I., Kandidátusi értekezés, 1973.Google Scholar
  51. 51.
    Jensen, K. Jensen, K. B., Olsen, H. Three M components in serum from an apparently healthy person. Scand. J. Haemat. 4,485. 1967.PubMedGoogle Scholar
  52. 52.
    Josephson, A. S., Nicastri, A., Price, E., Bíró, L. H μ-chain and monoclonal IgA in an hyperproliferative disorder. Amer. J. Med. 54,127.1973.PubMedGoogle Scholar
  53. 53.
    Kaboth, U., Kattermann, R., Arnold, R., Hauswaldt, C Immunoelektrophoretische Untersuchungen an einer pluriklonalen Gammopathie. Verh. Dtsch. Ges. inn. Med. 74,469.1968.PubMedGoogle Scholar
  54. 54.
    Keller, H., Spengler, G. A., Skvaril, F., Flury, W., Noseda, G.,Riva,G. Zur Frage der Heavy-Chain Disease. Ein Fall von IgG-he-avy-chain Fragment und IgM Typ K Paraproteinämie mit Plasmazellenleukämie. Schweiz. med. Wschr. 100,1012. 1970.PubMedGoogle Scholar
  55. 55.
    Keshgegian, A. A. Supression of one monoclonal immunoglobulin in the presence of another in multiple myeloma: evidence for benign B cell neoplasia. Cancer. 51,1097.1983.PubMedGoogle Scholar
  56. 56.
    Kubugawa, H., Vogler, C. B., Capra, J. D., Conrad, M.E., Lawton, A. R., Cooper, M. D. Studies on the clonal origin of multiple myeloma. J. Exp. Med. 150,792. 1979.Google Scholar
  57. 57.
    Levin, A. S., Rundenberg, H. H., Hopper, J. E., Wilson, S. K. Immunoflourescent evidence for cellular control of synthesis of variable regions of light and heavy chains of immunoglobulins G and M by the same gene. Proc. nat. Acad. Sci. 68,169.1971.PubMedGoogle Scholar
  58. 58.
    Liacopoulos, P., Amstutz, H., Gille, F. Early antibody-forming cells of double specificity. Immunology. 20,57.1971.PubMedGoogle Scholar
  59. 59.
    Lievre, J. A., Camus, J. P., Darcy, M., Crouzet, J., Guillien, P. Myélome avec tumeur iliaque (résection, reconstruction au ciment plastique, effect sur les paraprotéines). Ann. Med. Int. 122,663.1971.Google Scholar
  60. 60.
    Lucivero, G., Lawton, A. R., Cooper, M. D. Pokeweed-mitogen induced differentiation of human peripperal blood B-lymphocytes. II. Suppression of plasma cell differentiation by heavy-chain-specific antibodies and development of immunoglobulin class restriction. Hum. Lymph. Diff. 1,27. 1981.Google Scholar
  61. 61.
    Lucivero, G., Miglietta, A., Dell’Osso, A., Theodossio, G., Bonomo, L. Double (IgAK + IgGK) paraproteinaemia in a single patient: immunofluorescence evidence for a common plasma cell clone „frozen” at the switch phase. Acta Haemat. 75,224.1986.PubMedGoogle Scholar
  62. 62.
    Metz, K., Leder, L. D. A case of multiple myeloma with two subclones producing separately kappa and defective gamma chains. Cancer. 56,1392.1985.PubMedGoogle Scholar
  63. 63.
    Maldonato, J. E., Williams, R. C, Silverstein, M. N., Harrison, E. G. Lymphosarcoma with Bence Jones proteinuria (type kappa) and IgG serum M component (type lambda): a bitypic gammopathy. Proc. Mayo Clin. 45,413.1970.Google Scholar
  64. 64.
    McNutt, D. R., Fudenberg, H. H. IgG myeloma and Waldenström macroglobulinemia. Coexistence and clinical manifestations in one patient. Arch. Intern. Med. 131,731. 1973.PubMedGoogle Scholar
  65. 65.
    Mellors, R. C., Korngold, L. The cellular origin of human immunoglobulins (gamma-2, gamma-1M, gamma-1A). J. exp. Med. 118,387.1963.PubMedGoogle Scholar
  66. 66.
    Natvig, J. B., Kunkel, H. G. A hybrid IgG4-IgG2 immunoglobulin. J. Immunol. 112,1277. 1974.PubMedGoogle Scholar
  67. 67.
    Nisonoff, A., Hopper, J. E., Spring, S. B. The antibody molecule. Academic Press, N. Y., 1, 542. 1975.Google Scholar
  68. 68.
    Nossal, G. J. V., Szenberg, A., Ada, G. L., Austin, C. M. Single cell studies on 19S antibody production. J. exp. Med. 119,485. 1964.PubMedGoogle Scholar
  69. 69.
    Nowell, P. C. Genetic instability in cancer cells: relationship to tumor cell heterogeneity. In: Tumor cell heterogeneity: origins and implications. Ed. by Owens, A. H., Coffey, D. S., Baylin, J. B. New York Academic Press. 351. 1982.Google Scholar
  70. 70.
    Oriol, R., Barvier, Y., Biozzi, G. Hybrid 7S immunoglobulin molecules formed in vivo by association of heavy and light chains of differenct parental origin. European J. Immunol. 2,105. 1972.Google Scholar
  71. 71.
    Oriol, R., Huerta, J., Bouvet, J. P., Liacopoulos, P. Two myeloma globulins, IgG1-K and IgG1-L, from a single patient (Im) I. Purification and immunochemical characterization. Immunology. 27,1081.1974.PubMedGoogle Scholar
  72. 72.
    Otto, Sz., Puskás, E., Medgyesi, G. A., Gergely, J. Diclonal and multiple gammapathies. Haematologia. 6,471.1972.PubMedGoogle Scholar
  73. 73.
    Oudin, J., Michel,M. Idiotype of rabbit antibodies. II. Comparison of idiotype of various kinds of antibodies formed in the same rabbits against Salmonella Typhi. J. exp. Med. 130,619. 1969.PubMedGoogle Scholar
  74. 74.
    Owen, J. A., Got, C., Silberman, H. J. Heterogeneity of serum myeloma globulins. Clin. chim. Acta. 3,605. 1958.PubMedGoogle Scholar
  75. 75.
    Oxelius, V. A. Alternating appearance of IgD and IgG myeloma protein during treatment. Scand. J. Haemat. 8,439. 1971.PubMedGoogle Scholar
  76. 76.
    Penn, G. M., Kunkel, H. G., Grey, H. M. Sharing of individual antigenic determinants between a gamma G and a gamma M proteins in the came myeloma serum. Proc. Soc. exp. Biol. Med. 35,66.1970.Google Scholar
  77. 77.
    Pernis, B., Forni, L., Amantel, L. Immunoglobulins as cell-receptors. Conference on immunoglobulins. Ann. N. Y. Acad. Sci. 190,420.1971.PubMedGoogle Scholar
  78. 78.
    Potter, M. Plasma-cell neoplasia in single host: a mosaic of different protein-producing cell types. J. exp. Med. 115,339.1962.PubMedGoogle Scholar
  79. 79.
    Prendergast, R. A., Grey, H. M., Kunkel, H. G. Recombination of heavy and light chains of human gamma A myeloma proteins: formation of hybrid molecules and confi-gurational specificity. J. exp. Med. 124,185. 1966.PubMedGoogle Scholar
  80. 80.
    Pruzanski, V., Underdown, B., Silver, E. H., Katz, A. Macroglobulinemia — myeloma double gammopathy. A study of four cases and a review of the literature. Amer. J. Med. 57,259.1974.PubMedGoogle Scholar
  81. 81.
    Radl,J.,Berg,P.V.D. Transitory appearance of homogenous immunoglobulins — „paraproteins” — in children with severe combined immunodeficiency, before and after transplantation treatment. In: Protides of the Biological Fluids 21st Colloquium. Ed: by Peeters H. Pergamon Press. 263.1973.Google Scholar
  82. 82.
    Rosen, B. J., Smith, T. W., Bloch, K. J. Multiple myeloma associated with two serum M components, gamma G type K and gamma A type L. Engl. J. Med. 17, 2. 1967.Google Scholar
  83. 83.
    Rudders, R. A., Heller, P. Double myeloma production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line. Amer. J. Med. 55,215. 1973.PubMedGoogle Scholar
  84. 84.
    Sanders, J. H., Fahey, J. L., Finegold. I., Ein, D., Reisfeld, R. Multiple anomalous immunoglobulins. Clinical, structural and cellular studies in the patients. Amer. J. Med. 47,43. 1969.PubMedGoogle Scholar
  85. 85.
    Scolari, L., Masai, C., Di Guglielmo, R. Il metodo dell’immunoperassidase Applicacioni allo studio delle cellule produttrici di Immunglobuline nel midolio asseo di pazienti affetti da gammopatie monoclonali. Boll. Soc. ital. Biol. sper. 50,549. 1974.PubMedGoogle Scholar
  86. 86.
    Scolari, L., Vaerman, J. P., Castigli, E., Voliani, D., Salvano, F., Masala, C., DiGuglielmo, R. Late appearance of an IgA-kappa monoclonal protein in a patient with IgG-kappa multiple myleoma: sharing of idiotypic specificities between the two serum proteins. Scand J. Immunol. 8,201. 1978.PubMedGoogle Scholar
  87. 87.
    Sega, E., Isabella, R., Citro, G. Two Bence Jones proteins of different immunological types light-chains (kappa and lambda) in a case of micromolecular myeloma. Boll. Ist. Sieroter. Milanese. 52,436.1973.Google Scholar
  88. 88.
    Seidel, K., Kühn, R. A., Kunstmann, F. W., Winnefeld, K. Mehrfache Proteinanomalien mit inkompletter Synthese und Spontanpräzipitation beim Plasmozytom. 2. Ges. inn. Med. 25, 704. 1970.Google Scholar
  89. 89.
    Silverman, A. Y., Yagi, Y., Pressman, D., Ellison, R. R., Tormey, D. Monoclonal IgA and IgM in the of a single patient III. Immunofluorescent identification of cells. J. Immunol. 110,350.1973.PubMedGoogle Scholar
  90. 90.
    Singurowicz, J., Murawski, K. Kraj, M., Jozwiak, W., Zupranska, B. Defective (incomplete) synthesis of immunoglobulin heavy polypeptide chains as the cause of a myeloma-like. Clin. chim. Acta. 22,187. 1968.Google Scholar
  91. 91.
    Skvaril, F., Juricic, D., Spengler, G. A., Morell, A. The IgG subclass distribution in dobule M component sera. In: Protides of the Biological Fluids 21st Colloquium. Ed. by Peeters, H. Pergamon Press. 273.1973.Google Scholar
  92. 92.
    Sledge,C.,Rair,D.S.,Black,D.,Krueger,R.G.,Hood,L. Antibody differentation apparent sequence indentity between variable regions shared by IgA and IgG immunoglobulins. Proc. nat. Acad. Sci. 73, 923. 1976.PubMedGoogle Scholar
  93. 93.
    Smithies, O. Antibody variability. Science. 157,267.1967.PubMedGoogle Scholar
  94. 94.
    Spengler, G. A., Steinberg, A. G., Skvaril, F. Development of a second monoclonal immunoglobulin G in a patient with late manifestation of myeloma. Acta med. scand. 192,309. 1972.PubMedGoogle Scholar
  95. 95.
    Stein, H., Kaiserling, E. Myeloma producing non secretory IgM and secretory IgG. Scand. J. Haemat. 12,274. 1974.PubMedGoogle Scholar
  96. 96.
    Sterzl,J.,Nordin,A. Demonstration of the cammon precursor for production of IgM and IgG antibodies. Folia microbiol. 16,1.1971.Google Scholar
  97. 97.
    Sterzl,J.,Nordin,A. The common cell precursor for cells producing different immunoglobulins. In: Cell interactions and receptor antibodies in immune responses. Ed.: by Mäkelä O., Cross, Anne, Kosunen, T. V. Academic Press, Inc., New York 213.1971.Google Scholar
  98. 98.
    Stoop, J. W., Ballieux, R. E., Weyers, H. A. Paraproteinemia with secondary immunoglobulin deficiency in an infant. Pediatrics. 29. 97.1962.PubMedGoogle Scholar
  99. 99.
    Szemere, P., Jákó, J., Szilágyi, G., Virágh, Sz. Oligoclonalis gammopathiák klinikai jelentősége. A Magyar Allergológiai és Klinikai Immunológiai Társaság VIII. Vándorgyűlése, Budapest, 1978.Google Scholar
  100. 100.
    Takahashi, M., Tanigaki, N., Yagi, Y., Moore, G. E., Pressman, D. Presence of two different immunoglobulin heavy-chains in individual cells of established human hematopoietic cell-lines. J. Immun. 100,1176. 1968.PubMedGoogle Scholar
  101. 101.
    Tormey, D. C., Ellison, R. R., Hossfeld, D. Concurrent monoclonal IgM and IgA proteins in lymphocytic lymphoma. Cancer. 36,1321. 1975.PubMedGoogle Scholar
  102. 102.
    Yagi, Y., Pressman, D. Monoclonal IgA and IgM in the serum of a single patient. Sharing of individually specific determinants between IgA and IgM. J. Immunol. 110,335. 1973.PubMedGoogle Scholar
  103. 103.
    Villiaumey, J., Bouvet, J. P., Di Menza, C., Boccara, M. Myélome plasmocytaire „monoclonal” à deux paraprotéines, IgG kappa et IgG lambda. Nouv. Presse Méd. 3,2707. 1974.Google Scholar
  104. 104.
    Vitetta, E. S., Uhr, J. W. Immunoglobulin-receptors, revisited. Science. 189,964.1975.PubMedGoogle Scholar
  105. 105.
    Von Oberdörfer, A., Schnauffer, K., Lange, H. J., Neiss, A. Zur Verteilung von Paraproteinmien nach Geschlecht und Alter der Patienten, Paraprotein-Klassen-Subklassen und Leichketten-Typen. Z. klin. Chem. 8, 51. 1973.Google Scholar
  106. 106.
    Wang, A. C., Wang, I. Y. F., McCormick, J. N., Fudenberg, H.H. The identity of light-chains of monoclonal IgG and monoclonal IgM in one patient. Immunochemistry. 6,451. 1969.PubMedGoogle Scholar
  107. 107.
    Wang, A. C., Wilson, S. K., Hopper, J. E., Fudenberg, H. H.,Nisonoff,A. Evidence for control of synthesis of the regions of the heavy chains of immunoglobulins G and M by same gene. Proc. nat. Acad. Sci. 66, 337.1970.PubMedGoogle Scholar
  108. 108.
    Wang, A. C., Fudenberg, H. H., Goldrosen, M. H., Freedman, M. H. Chemical studies of heavy chains of two IgG1-lambda myeloma proteins from a single patient. Immunochemistry. 9,473.1972.PubMedGoogle Scholar
  109. 109.
    Wang, A. C., Gergely, J., Fudenberg, H. H. Amino acid sequences at constant and variable regions of heavy chains of monotypic immunoglobulins G and M of a single patient. Biochemistry. 12,528. 1973.PubMedGoogle Scholar
  110. 110.
    Wolfenstein-Todel, C., Franklin, E. C., Rudders, R. A. Similarities of the light-chains and the variable regions of the heavy-chains of the IgG2-lambda and IgA1lambda myeloma proteins from a single patient. J. Immunol. 112,871. 1974.PubMedGoogle Scholar
  111. 111.
    Zawadzki, Z. A., Edwards, G. A. M components in immunoproliferative disorders. Amer. J. Clin. Path. 48,418.1967.Google Scholar

Copyright information

© Jákó János, Budapest 1991

Authors and Affiliations

  • János Jákó
    • 1
  1. 1.1st Department of MedicinePostgraduate Medical SchoolBudapestHungary

Personalised recommendations